Similar phenomenon occurs in bladder cancer, so that curcumin administration (0–50 μM) decreases CD44, CD133, ALDH1, Nanog and Oct4 to impair CSC characteristics in bladder cancer and induce apoptosis and proliferation inhibition. The gene discussed is POU5F1; the disease is urinary bladder carcinoma.